FT News Briefing Final US presidential debate, FDA approves remdesivir, Intel data hit by pandemic
Oct 23, 2020
Demetri Sevastopulo, Washington bureau chief for the Financial Times, dives into the key moments of the final face-off between Trump and Biden, shedding light on their contrasting pandemic responses and foreign policy stances. He highlights Texas's shifting political landscape as local races may redefine the national political scene for years. Additionally, the episode covers Gilead's FDA approval of remdesivir for COVID-19 treatment and Intel's significant revenue decline, illustrating the pandemic's impact on major corporations.
AI Snips
Chapters
Transcript
Episode notes
Final Presidential Debate Highlights
- Trump and Biden clashed in their final presidential debate.
- The debate covered topics ranging from COVID-19 to race relations.
Texas Politics Shifting
- Texas has been a Republican stronghold due to conservative demographics and the oil boom.
- However, demographic shifts and Beto O'Rourke's 2018 Senate run have energized Democrats.
Importance of Statehouse Races
- Statehouse races are crucial for redistricting, impacting national politics.
- Democrats aim to regain control of state legislatures to influence future elections.